Dextrose
targets TRPV1 via inhibition
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | DEXTROSE 70% IN PLASTIC CONTAINER | — | 2000-12-07 | fda.gov ↗ |
| Label expansion | US (FDA) | DEXTROSE 50% | — | 1998-11-23 | fda.gov ↗ |
| Approved | US (FDA) | ALCOHOL 5% AND DEXTROSE 5% | — | 1946-01-17 | fda.gov ↗ |
Trials 78 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT04832009 | May 2022 → Aug 2026 overdue | hypertensive disorder | University of Kansas Medical Center | Recruiting | No outcome recorded |
| Phase 0 | NCT04945499 | Jun 2019 → Jun 2022 | — | Zhujiang Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT03801226 | Dec 2018 → May 2019 | symptomatic heart failure | Yale University | Completed | No outcome recorded |
| Phase 14 trials | ||||||
| Phase 1 | NCT05780086 | Feb → Aug 2023 | chronic kidney disease | Mexican Social Security Institute | Unknown | No outcome recorded |
| Phase 1 | NCT05185999 | Oct 2022 → Oct 2023 | chronic renal failure syndrome | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 1 | NCT04640662 | Feb 2020 → Jun 2021 | tendinosis | University of Malaya | Completed | No outcome recorded |
| Phase 1 | NCT03205553 | Feb → May 2018 | gastroschisis | University of Arkansas | Terminated | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT07688096 | Jul 2026 → Sep 2027 expected | Ehlers-Danlos syndrome, hypermobility type, chronic pain syndrome, hypermobility spectrum disorder, hypermobility syndrome | Manhattan Pain Medicine, PLLC | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT06829030 | Jul 2024 → Feb 2025 overdue | — | Aksaray University Training and Research Hospital | Enrolling by invitation | No outcome recorded |
| Phase 27 trials | ||||||
| Phase 2 | NCT07548047 | Jun 2026 → Jun 2028 expected | — | Thomas Jefferson University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06293885 | Mar 2024 → Apr 2025 | — | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Unknown | No outcome recorded |
| Phase 2 | NCT05160532 | Apr 2022 → May 2025 | osteoarthritis, knee | Mayo Clinic | Completed | No outcome recorded |
| Phase 2 | NCT04557878 | Oct 2020 → Apr 2021 | temporomandibular joint disorder | Nourhan M.Aly | Completed | No outcome recorded |
| Phase 2 | NCT02796729 | Oct 2016 → Dec 2018 | metastatic malignant neoplasm in the brain | British Columbia Cancer Agency | Terminated | No outcome recorded |
| Phase 2 | NCT01897259 | Mar 2012 → Jun 2019 | epicondylitis | Christine M. Kleinert Institute for Hand and Microsurgery | Unknown | No outcome recorded |
| Phase 2 | NCT01285713 | Sep 2010 → Aug 2011 | — | Children's Hospital of Philadelphia | Completed | No outcome recorded |
| Phase 2/35 trials | ||||||
| Phase 2/3 | NCT06859034 | Mar → Sep 2025 overdue | temporomandibular joint disorder | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT05548738 | Apr 2022 → Nov 2023 | chronic pain syndrome | Alexandria University | Completed | No outcome recorded |
| Phase 2/3 | NCT04802785 | Jun → Jul 2021 | — | Dinara Zhumanbayeva | Unknown | No outcome recorded |
| Phase 2/3 | NCT01210183 | Jul 2010 → Dec 2013 | osteoarthritis, knee | Universidad Nacional de Rosario | Completed | No outcome recorded |
| Phase 2/3 | NCT00674622 | Sep 2007 → Oct 2010 | epicondylitis | University of Pittsburgh | Completed | No outcome recorded |
| Phase 35 trials | ||||||
| Phase 3 | NCT05279937 | Jun 2026 → Jun 2027 expected | Ehlers-Danlos syndrome | Tulane University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07102225 | May 2025 → Sep 2026 expected | osteoarthritis, knee | Bangladesh Medical University | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06847594 | Feb → Sep 2024 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT04791202 | Apr 2021 → Mar 2022 | — | Christine M. Kleinert Institute for Hand and Microsurgery | Unknown | No outcome recorded |
| Phase 3 | NCT00091507 | Nov 2006 → Aug 2011 | congestive heart failure, intermediate coronary syndrome, myocardial infarction | Tufts Medical Center | Completed | No outcome recorded |
| Phase 417 trials | ||||||
| Phase 4 | NCT07382596 | May 2026 → Mar 2030 expected | post-traumatic stress disorder | Dr. Dean Reeves Clinic | Recruiting | No outcome recorded |
| Phase 4 | NCT06726980 | Jan 2025 → Jan 2026 overdue | — | Assiut University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06349824 | Oct 2023 → Mar 2024 | carpal tunnel syndrome | Sheikh Zayed Medical College | Completed | No outcome recorded |
| Phase 4 | NCT05977985 | Aug 2023 → Jul 2024 | frozen shoulder | University of Malaya | Unknown | No outcome recorded |
| Phase 4 | NCT05918146 | Jun 2023 → Jun 2024 | subacute bursitis | Taipei Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT05264727 | May 2023 → Dec 2025 overdue | obesity disorder, type 2 diabetes mellitus | Mayo Clinic | Active not recruiting | No outcome recorded |
| Phase 4 | NCT05721404 | May 2023 → Apr 2027 expected | — | First Affiliated Hospital, Sun Yat-Sen University | Recruiting | No outcome recorded |
| Phase 4 | NCT05131269 | Dec 2021 → May 2022 | frozen shoulder | Bumi Herman | Completed | No outcome recorded |
| Phase 4 | NCT03693287 | Jul 2021 → Aug 2023 | pulmonary immaturity | Ospedali Riuniti Ancona | Unknown | No outcome recorded |
| Phase 4 | NCT04062838 | Aug 2020 → Dec 2021 | rotator cuff syndrome | Hadassah Medical Organization | Withdrawn | No outcome recorded |
| Phase 4 | NCT04165902 | Nov 2019 → Jul 2020 | osteoarthritis, knee | Taipei Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT04557943 | Sep 2019 → Apr 2020 | osteoarthritis, knee | Hasanuddin University | Completed | No outcome recorded |
| Phase 4 | NCT07020455 | Jan 2019 → Jan 2022 | hypermobility syndrome, temporomandibular joint disorder | Karadeniz Technical University | Completed | No outcome recorded |
| Phase 4 | NCT02590081 | Oct 2015 → Oct 2016 | end stage renal failure | Penang Hospital, Malaysia | Unknown | No outcome recorded |
| Phase 4 | NCT02984098 | Sep 2014 → Jun 2015 | — | University of Targu Mures, Romania | Completed | No outcome recorded |
| Phase 4 | NCT01934868 | Dec 2013 → Apr 2023 | lumbar disk degenerative disorder, lumbar spinal stenosis, sciatica | Hadassah Medical Organization | Completed | No outcome recorded |
| Phase 4 | NCT01938755 | Jun 2013 → Jan 2014 | — | Ordu University | Completed | No outcome recorded |
| Phase not applicable35 trials | ||||||
| — | NCT07498998 | Jul → Aug 2026 overdue | carpal tunnel syndrome | Tanta University | Not yet recruiting | No outcome recorded |
| — | NCT06872645 | Oct 2025 → Jun 2028 expected | — | Yale University | Recruiting | No outcome recorded |
| — | NCT07559058 | Oct 2025 → Jan 2026 | frozen shoulder, rotator cuff syndrome | Rizki Darmawan | Completed | No outcome recorded |
| — | NCT07479693 | Jan → Aug 2025 | hydrarthrosis, temporomandibular joint disorder | Ondokuz Mayıs University | Completed | No outcome recorded |
| — | NCT06617065 | Sep 2024 → Jan 2025 overdue | chronic pain syndrome | The Seekers Centre | Active not recruiting | No outcome recorded |
| — | NCT06165939 | Jan → Dec 2024 | frozen shoulder | Tri-Service General Hospital (TSGH) | Unknown | No outcome recorded |
| — | NCT06165926 | Jan → Dec 2024 | frozen shoulder | Tri-Service General Hospital (TSGH) | Unknown | No outcome recorded |
| — | NCT05984121 | Aug → Dec 2023 | plantar fasciitis | Ahi Evran University Education and Research Hospital | Completed | No outcome recorded |
| — | NCT05966948 | May → Sep 2023 | obesity disorder, osteoarthritis, knee | Rumah Sakit Umum Daerah Haji Provinsi Jawa Timur, Indonesia | Completed | No outcome recorded |
| — | NCT06301958 | Jan 2023 → Aug 2024 | arthropathy | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| — | NCT05429827 | Nov 2022 → Jun 2024 | myofascial pain syndrome | National Cheng-Kung University Hospital | Completed | No outcome recorded |
| — | NCT05239091 | Aug 2022 | myofascial pain syndrome | Istanbul Physical Medicine Rehabilitation Training and Research Hospital | Completed | No outcome recorded |
| — | NCT05154695 | Aug 2021 → Oct 2023 | chronic pain syndrome, musculoskeletal system disorder | National Taiwan University Hospital | Completed | No outcome recorded |
| — | NCT04014244 | Mar 2021 → Mar 2022 | carpal tunnel syndrome | University Medical Centre Ljubljana | Unknown | No outcome recorded |
| — | NCT04979273 | Mar → Dec 2021 | — | Dr Cipto Mangunkusumo General Hospital | Unknown | No outcome recorded |
| — | NCT04178304 | Dec 2019 → Oct 2021 | osteoarthritis, knee | University of Alexandria | Completed | No outcome recorded |
| — | NCT04492150 | Sep 2019 → Sep 2020 | — | Suez Canal University | Unknown | No outcome recorded |
| — | NCT04821882 | May 2019 → Sep 2020 | interstitial cystitis | National Defense Medical Center, Taiwan | Completed | No outcome recorded |
| — | NCT04206579 | Mar → May 2019 | — | Hasanuddin University | Completed | No outcome recorded |
| — | NCT03839108 | Dec 2018 | osteoarthritis, hand | Bakirkoy Dr. Dr. Sadi Konuk Research and Training Hospital | Completed | No outcome recorded |
| — | NCT03400631 | Aug 2018 → Nov 2021 | osteoarthritis, knee | Fisiatria y Traumatología | Completed | No outcome recorded |
| — | NCT04509440 | May 2018 → Oct 2019 | pes anserinus tendinitis or bursitis | University of Alexandria | Completed | No outcome recorded |
| — | NCT04499911 | Apr 2018 → Sep 2019 | meralgia paresthetica | University of Alexandria | Completed | No outcome recorded |
| — | NCT02990962 | Dec 2016 → Apr 2018 | carpal tunnel syndrome | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| — | NCT02989675 | Dec 2016 → Jan 2019 | childhood acute lymphoblastic leukemia, hypoglycemia | Helena Hildenwall | Terminated | No outcome recorded |
| — | NCT02809261 | May 2016 → Mar 2017 | carpal tunnel syndrome | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| — | NCT02888795 | Feb 2016 → May 2017 | osteoarthritis, knee | National Yang Ming Chiao Tung University Hospital | Completed | No outcome recorded |
| — | NCT02376218 | Apr 2015 → Feb 2016 | — | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| — | NCT02476448 | Feb 2015 → Feb 2016 | ureteral disorder | Cecilia Calvo | Completed | No outcome recorded |
| — | NCT01912807 | Dec 2013 → Sep 2014 | — | University of Saskatchewan | Completed | No outcome recorded |
| — | NCT01825720 | Mar → May 2013 | heart valve disorder | Yonsei University | Completed | No outcome recorded |
| — | NCT01688674 | Feb → Apr 2012 | — | Makerere University | Terminated | No outcome recorded |
| — | NCT01151605 | Sep 2008 → Sep 2013 | — | University at Buffalo | Completed | No outcome recorded |
| — | NCT00685880 | May 2008 → Jul 2010 | osteoarthritis, hand | Mayo Clinic | Terminated | No outcome recorded |
| — | NCT00774098 | Jan 2007 → Sep 2009 | — | McGill University Health Centre/Research Institute of the McGill University Health Centre | Completed | No outcome recorded |
Also used as a comparator or background therapy in 62 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 04 trials | ||||||
| Phase 0 | NCT07296653 Comparator | Dec 2025 → Dec 2026 expected | — | National and Kapodistrian University of Athens | Recruiting | No outcome recorded |
| Phase 0 | NCT04133922 Comparator | Oct 2019 → Oct 2023 | type 1 diabetes mellitus | University of Virginia | Withdrawn | No outcome recorded |
| Phase 0 | NCT03520569 Comparator | Feb 2019 → Apr 2021 | arterial disorder | University of Virginia | Completed | No outcome recorded |
| Phase 0 | NCT02982551 Background | Jan 2016 → Dec 2017 | — | University of Pittsburgh | Withdrawn | No outcome recorded |
| Phase 15 trials | ||||||
| Phase 1 | NCT06592261 Background | Sep 2024 → Aug 2026 overdue | hyperinsulinism, obesity disorder | Columbia University | Recruiting | No outcome recorded |
| Phase 1 | NCT05724134 Background | Aug 2023 → Sep 2025 | NAFLD1, hyperinsulinism, obesity disorder, prediabetes syndrome | Columbia University | Completed | No outcome recorded |
| Phase 1 | NCT03095651 Background | Apr 2017 → Jan 2018 | type 1 diabetes mellitus, type 2 diabetes mellitus | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 1 | NCT02971202 Background | Dec 2016 → Feb 2019 | maturity-onset diabetes of the young type 2, type 1 diabetes mellitus | Vanderbilt University | Completed | No outcome recorded |
| Phase 1 | NCT02269735 Background | Nov 2014 → Jul 2016 | type 1 diabetes mellitus | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 25 trials | ||||||
| Phase 2 | NCT06911359 Comparator | Mar 2025 → Dec 2026 expected | osteoarthritis, knee | David Grant U.S. Air Force Medical Center | Recruiting | No outcome recorded |
| Phase 2 | NCT04603014 Background | Jan 2021 → Dec 2026 expected | end stage renal failure | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Active not recruiting | No outcome recorded |
| Phase 2 | NCT02632630 Comparator | Mar 2016 → Feb 2018 | nutritional deficiency disease | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 2 | NCT01547364 Comparator | Feb 2012 → Oct 2013 | — | Smigel, Liza, M.D. | Completed | No outcome recorded |
| Phase 2 | NCT01281761 Background | Nov 2010 → Sep 2012 | colorectal cancer | Samsung Medical Center | Completed | No outcome recorded |
| Phase 2/33 trials | ||||||
| Phase 2/3 | NCT02752308 Comparator | Sep 2014 → Mar 2015 | hypospadias | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT02185729 Comparator | Jun 2008 → Mar 2012 | metabolic disease | Emory University | Completed | No outcome recorded |
| Phase 2/3 | NCT00835939 Comparator | Sep 2007 → Jan 2010 | enthesopathy, tendinosis | University of Calgary | Unknown | No outcome recorded |
| Phase 37 trials | ||||||
| Phase 3 | NCT06045013 Comparator | Sep 2023 → Jan 2026 overdue | carpal tunnel syndrome | General and Veteran Hospital Croatian Pride Knin | Recruiting | No outcome recorded |
| Phase 3 | NCT05326763 Comparator | May 2021 → Dec 2022 | epicondylitis | Chen Yueh | Unknown | No outcome recorded |
| Phase 3 | NCT02728037 Background | Apr 2016 → Mar 2020 | pelvis syndrome | Queen's University | Terminated | No outcome recorded |
| Phase 3 | NCT01909336 Comparator | Jul 2013 → Feb 2014 | — | Instituto Tecnologico y de Estudios Superiores de Monterey | Completed | No outcome recorded |
| Phase 3 | NCT00632775 Comparator | Dec 2007 → Sep 2012 | — | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 3 | NCT00457873 Comparator | Jan 2007 → Apr 2008 | bronchiolitis, gastroenteritis, infectious disease with sepsis, urinary tract infection | McGill University Health Centre/Research Institute of the McGill University Health Centre | Completed | No outcome recorded |
| Phase 3 | NCT00220766 Background | Aug 2002 | Wiskott-Aldrich syndrome, common variable immunodeficiency, severe combined immunodeficiency | Grifols Therapeutics LLC | Completed | No outcome recorded |
| Phase 418 trials | ||||||
| Phase 4 | NCT07494084 Comparator | Jul 2026 → Mar 2029 expected | circadian rhythm sleep disorder, shift work type | Washington State University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07283874 Comparator | Dec 2025 → Dec 2026 expected | carpal tunnel syndrome | Assiut University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07124130 Comparator | Sep 2025 → Mar 2026 overdue | — | Eastern Virginia Medical School | Recruiting | No outcome recorded |
| Phase 4 | NCT07105540 Comparator | Aug 2025 → Feb 2026 | carpal tunnel syndrome | Ankara Etlik City Hospital | Completed | No outcome recorded |
| Phase 4 | NCT06349265 Comparator | Oct 2023 → Feb 2024 | carpal tunnel syndrome | Kastamonu University | Completed | No outcome recorded |
| Phase 4 | NCT06036823 Comparator | Oct 2023 → Sep 2025 | mineral metabolism disease | Oman Medical Speciality Board | Completed | No outcome recorded |
| Phase 4 | NCT07015450 Comparator | May → Aug 2023 | — | Indonesia University | Completed | No outcome recorded |
| Phase 4 | NCT04941118 Comparator | Jul → Dec 2021 | — | Mustafa Kemal University | Unknown | No outcome recorded |
| Phase 4 | NCT04949139 Comparator | May 2021 → Jan 2025 | — | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04680936 Comparator | Jan 2021 → May 2022 | epicondylitis | Ahi Evran University Education and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04958213 Comparator | Sep 2020 → Jun 2021 | osteoarthritis, knee | Mustafa Kemal University | Completed | No outcome recorded |
| Phase 4 | NCT04012138 Background | Dec 2019 → Dec 2025 | — | Nantes University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02746432 Background | Jan 2018 → Mar 2021 | colon carcinoma | King Saud University | Unknown | No outcome recorded |
| Phase 4 | NCT03238183 Comparator | Aug 2017 → Jul 2019 | — | Taipei Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT02492945 Comparator | Jun 2015 → Sep 2016 | epicondylitis | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03956303 Comparator | Jun 2014 → Jun 2016 | — | Balikesir University | Completed | No outcome recorded |
| Phase 4 | NCT02102243 Background | Nov 2010 → Dec 2025 | hypertensive disorder | Wanpen Vongpatanasin | Withdrawn | No outcome recorded |
| Phase 4 | NCT00749827 Comparator | — | acute tubulointerstitial nephritis | Memorial University of Newfoundland | Withdrawn | No outcome recorded |
| Phase not applicable20 trials | ||||||
| — | NCT07564063 Comparator | Jun → Dec 2026 expected | — | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT07451561 Comparator | Mar 2026 → Mar 2027 expected | — | Sohag University | Not yet recruiting | No outcome recorded |
| — | NCT07524933 Comparator | Jan → Jul 2026 overdue | — | Antalya Training and Research Hospital | Active not recruiting | No outcome recorded |
| — | NCT07245121 Comparator | Nov 2025 → Dec 2026 expected | chronic pain syndrome, osteoarthritis, knee | National and Kapodistrian University of Athens | Recruiting | No outcome recorded |
| — | NCT07241559 Comparator | Nov 2025 → Apr 2026 overdue | chronic pain syndrome | Ankara City Hospital Bilkent | Recruiting | No outcome recorded |
| — | NCT07428512 Comparator | Jul → Dec 2025 | chronic pain syndrome | Ankara City Hospital Bilkent | Completed | No outcome recorded |
| — | NCT07503574 Comparator | Apr → Jul 2025 | myofascial pain syndrome | Ankara University | Completed | No outcome recorded |
| — | NCT07002892 Comparator | Jan 2025 → Jan 2026 overdue | carpal tunnel syndrome | Yunus Burak Bayır | Recruiting | No outcome recorded |
| — | NCT07355712 Background | Jul 2024 → Oct 2025 | — | Gadjah Mada University | Completed | No outcome recorded |
| — | NCT06126419 Background | Nov 2023 → Jul 2026 overdue | liver disorder, metastasis from malignant tumor of colon | McGill University Health Centre/Research Institute of the McGill University Health Centre | Recruiting | No outcome recorded |
| — | NCT06161038 Comparator | Oct 2023 → Jul 2025 overdue | chronic pain syndrome, idiopathic scoliosis | National Taiwan University Hospital | Recruiting | No outcome recorded |
| — | NCT05177263 Comparator | Jun 2022 → Jun 2023 | — | Guzide UGUCU | Completed | No outcome recorded |
| — | NCT04887480 Comparator | May 2021 → May 2025 | — | Sanford Health | Suspended | No outcome recorded |
| — | NCT04264000 Comparator | Aug 2020 → Mar 2024 | ulnar neuropathy | Yung-Tsan Wu | Completed | No outcome recorded |
| — | NCT04395417 Comparator | May → Sep 2018 | epicondylitis | Hacettepe University | Completed | No outcome recorded |
| — | NCT04150978 Comparator | Oct 2017 → Mar 2018 | — | Hasanuddin University | Completed | No outcome recorded |
| — | NCT02653092 Background | Jun 2016 → Dec 2023 overdue | hyperinsulinism, hypogonadotropic hypogonadism, infertility disorder, obesity disorder | University of Colorado, Denver | Active not recruiting | No outcome recorded |
| — | NCT02331069 Comparator | Jan 2015 → Jan 2016 | radial nerve lesion | Universidad Abierta Interamericana | Unknown | No outcome recorded |
| — | NCT01271140 Background | Jan 2011 → Dec 2013 | hepatitis C induced liver cirrhosis | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| — | NCT00753142 Comparator | Mar 2004 → Dec 2009 | type 2 diabetes mellitus | Emory University | Completed | No outcome recorded |
Evidence & citations 17 cited values
Every value below carries the sentence it was read from. 143 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dextrose | “Intra-articular injection with 25% dextrose will be carried out with the following details: 5 mL of 40% dextrose, 2 mL of lidocaine, and 1 mL of aqua dest are inserted into the...” NCT04557943 ↗135“bolus of 1-3 IU/kg regular insulin together with 0.5-1 gm/kg dextrose followed by an intravenous infusion of 0.2 to 1 IU/kg/hr of regular insulin and a dextrose infusion will...” NCT07451561 ↗ “1.5 cc 30% dextrose solution and 1.5 cc 2 lidocaine mixture with a 25 gauge needle into the medial plantar region cc 2 lidocaine mixture will be made sterile with 3 cc 15% dextrose.” NCT05984121 ↗ “Prolotherapy group Patients in the prolotherapy group will receive a single 2 mL injection of 16.5% dextrose solution administered under ultrasound guidance.” NCT04640662 ↗ “Participants receive a glucose infusion consisting of 10% dextrose infused intravenously at a rate of 200 mg/m\^2/min for 20 hours.” NCT00753142 ↗ “Intravenous glucose will be "dextrose 50%", amino acids (AA) will be "Primene®" and lipids (FAT) will be "Clinoleic®".” NCT03693287 ↗ “Subjects participating in the prolotherapy group will recieve 1 cc 50% Dextrose and Sodium Morrhuate 1 cc injections.” NCT01897259 ↗ “Patients were infiltrated with 5cc of dextrose 15% at the lateral epicondyle according to the standard technique.” NCT04395417 ↗ “prior controlled study reported short-term pain relief after caudal epidural injection of 5% dextrose (D5W)” PMID 29883193 ↗ Jun 2018 “Intravenous sodium bicarbonate (130 mEq/L) in 4.35% dextrose at 3.5 ml/Kg over 1 hour pre-contrast” NCT00749827 ↗ “an Infusion of dextrose 20% supplemented with pottasium phosphate (30 mmol/L ) to be administered.” NCT02746432 ↗ “a titrating dose of 20% dextrose aiming to a blood glucose level of 4 - 5.5 mmol/l.” NCT01271140 ↗ “In one-liter: Dextrose 30% + 80 mEq Potassium Chloride + 50 units Regular Insulin” NCT00091507 ↗ “dextrose plus hyaluronic acid injection, one time per week, for 3 weeks” NCT04165902 ↗ “dextrose 20% supplemented with phosphate (30 mmol/L) will be infused.” NCT06126419 ↗ “500 ml of 10% dextrose in water administered over a 30-minute period” NCT04012138 ↗ “Injection of 15% dextrose with lidocaine at the lateral epicondyle” NCT00674622 ↗ “D1 Irinotecan 150-180mg/m2 + Dextrose 5% 500ml IV \[over 90min\]” NCT01281761 ↗ “Drug = prolotherapy (%15 dextrose solution) into hand joints” NCT03839108 ↗ “Chirocaine (%0.75) + Dextrose 40 mg+20 mcg fentanyl” NCT03956303 ↗ “30% dextrose water with 80 mmol/l of potassium” NCT01825720 ↗ “20 mL of 15% hypertonic dextrose solutions” NCT07355712 ↗ “The injectant is 5ml 5% dextrose solution.” NCT06161038 ↗ “normal saline, dextrose, lactated Ringer's” NCT02632630 ↗ “The injectant is 5ml 5% dextrose solution.” NCT05154695 ↗ “levobupivacaine plus 60 mg dextrose” NCT01938755 ↗ “Dextrose 13.5 g per os” NCT04802785 ↗ |
| Known as | 20% D-glucose (aq) | “20% D-glucose (aq) (D20W) will be administered to counteract hypoglycemia or strongly downward blood glucose trends, as needed.” NCT05724134 ↗ |
| Known as | 5% Dextrose | “500 ml of 5% Dextrose administered to a peripheral vein.” NCT04150978 ↗ |
| Known as | 5% dextrose injection | “Drug: 5% dextrose injection” NCT07241559 ↗ |
| Known as | d-glucose | “Prolo Group: All participants will receive 15% dextrose (D-glucose) with 1% lidocaine.” NCT07296653 ↗ |
| Known as | D10W | “dextrose 10% (D10W ®) infusion” NCT00774098 ↗ |
| Known as | D20W | “20% D-glucose (aq) (D20W) will be administered to counteract hypoglycemia or strongly downward blood glucose trends, as needed.” NCT05724134 ↗ |
| Known as | D5W | “perineural injection of peripheral nerves, plexi, or sympathetic ganglia with dextrose 5% in water (D5W), has performed well empirically in the treatment of post-traumatic...” NCT07382596 ↗4“The effect of injecting 1 mL each of normal saline and 5% dextrose in water (NS and D5W) on muscle twitch was investigated at all 20 needle insertion sites.” PMID 15138901 ↗ May 2004 “Perineural injection with 5% dextrose (D5W).” NCT07498998 ↗ “Drug: Dextrose 5% (D5W)” NCT02331069 ↗ “5% dextrose (D5W)” PMID 31368191 ↗ Aug 2019 |
| Known as | Dextrose 20 % in Water | “Drug: Dextrose 20 % in Water” NCT04133922 ↗ |
| Known as | Dianeal PD-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04887480 ↗ |
| Known as | Glucose | “Using Dextrose (Glucose) Gel to Reverse Neonatal Hypoglycemia.” PMID 28764827 ↗ Jul 2017 |
| Known as | perineural dextrose injection | “perineural dextrose injection” NCT07002892 ↗ |
| Known as | Peritoneal Dialysis Solution/Dextrose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03205553 ↗ |
| Action | Inhibit | “5% Dextrose could decrease the release of CGRP and substance P to reduce the nerve inflamation.” NCT02809261 ↗ |
| Modality | Diagnostic / imaging agent | “using d-glucose as an contrast agent on CEST MR Imaging” NCT04945499 ↗ |
| Route | Intravenous | “Intravenous solution” NCT00091507 ↗ |
| Target | TRPV1 | “Perineural prolotherapy (glucose concentration DW 5%) seems to exert therapeutic effects by inhibiting the activation of the TRPV1 pain receptor located at the terminals of...” NCT07245121 ↗ |